| Tag | Content |
|---|
EnhancerAtlas ID | HS129-21353 |
Organism | Homo sapiens |
Tissue/cell | MCF10A |
Coordinate | chr2:224679400-224681220 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ESX1 | MA0644.1 | chr2:224680957-224680967 | GTTAATTGGT | - | 6.02 | | EWSR1-FLI1 | MA0149.1 | chr2:224681028-224681046 | TATTCCTTCCTTCCTCCC | - | 7.54 | | Lhx3 | MA0135.1 | chr2:224680114-224680127 | GGTTAATTAATTC | - | 6.41 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_34580 | chr2:224677950-224684631 | HCT-116 | | SE_58571 | chr2:224649001-224703710 | Ly1 | | SE_61207 | chr2:224650418-224703645 | HBL1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 3 | Chromosome | Start | End |
| chr2 | 224679785 | 224680466 | | chr2 | 224680536 | 224680631 | | chr2 | 224681044 | 224681185 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I223813 | chr2 | 224677833 | 224683210 |
|
Enhancer Sequence | GAGGTTTGCA CATTAAACTA AAAAATATGA CAGGCGTTCT AAGACTATAC AGGAGATTTC 60
AGGCTGACAA TAAGAACTAA GACTCAATGT TTATTTATTT TTCTTTAATT TGAAACAGGG 120
TCTTACTCTG TCACCCAGGC TGGTGTACAA TGGCACGATC ACAGCTCACT GCAGCCTCAA 180
CCTCCTGGGC TCAGGAGATC CTCCTGCCTT AGCCTCCCAA GTAGCTGGGA CCACAGGTAC 240
ACACTATCAC TCCGGGCTAA TTCTTTTATC TGTAGAAAGG GGTGTCTCAC TATGTTGCCA 300
GGCTGGTCTT GAACTCCTGG GCTCAAGCAA TTTTCCTGCC TTGGCCTCCC AAAGTGCTGG 360
GATTATAGGC ATGAGCCAGT GCACCTGGCC CCAATCTTTA TTTTAAATAA ATGTGATTTA 420
GTATTTGACT TAGACTTTCG ATTGATTTTA CCAATAGGGT GACAGAGTTA GCAAAACAAT 480
ACCACTGATT CTGAAAATAA ATGTCAATGT GCCATAAACC ATGTTGGAAA AATCTTTGAG 540
TACTTTTTGG CATCAAACCA AGAACACAGT CATCAGTTCT CCTTGCTTGG TAAATTTTAG 600
TCATGGGCTG TAGTCTATGA CACATCTTTG AGAGGCAGAC TTTGAAGGAG CTAATGCTGG 660
CAGAAACCAA CCAGGGTTGA TTTTGGATGC AATCCAAGGA AAGCAGAAAG ATCAGGTTAA 720
TTAATTCCAG TCAGCCCTAA GTAATGATTC TTTAGGGTCT GACCCAACTC TCAAAACAAA 780
AATCACTTTC CCTCCCAAGT TTACGAGCCA CCTTCAAATT CCTGAGGACT GCGGTACTAA 840
CCAACCTAAA ATGAATGCAT GCATAGATTT GTAAAGCCAA CCAAACTTGT GAACCCTGAA 900
AAACTAAGGT AATCAGTCTT AGTTTCCTAA TAAATATAAA AGTGTTTTAA TTCCACAGCA 960
AATAATCCAA GCATATAAAC TGTTCTTATG CATACAGTAC TCTGTATTCC ACAGAATATA 1020
ATACAGTTTT TAAGCCCTCA CTTAACTTCA GCAATAGATT CTTGAAAACT GCAACTTTAA 1080
GCAAAACAAC ATACTATGTA ACAAAACTAA TTTTGCCACA GGCTAATTGA TAGAAACAAG 1140
AGTCAGGGAC AGGCAGTGGC TCAGGTCTCT AATACTAGCA CTACGGGAGG CTAAGGGAGG 1200
AAGACAGCTT GAGCCCAGGA GTTCGAGACC AGCCTGGGCA ACACAGTGAA ACCACATCTG 1260
TACAAAAAAT ACAAAAATTA TCTGGGTATG GTGGCATATG CCTGTGGTCC CAGCTACTCA 1320
GGAGGCTGAA GTGGGAGGAT CATTTGAGCC TGGGAGGCTG AGGCTGCAGT GAGCCGTGAT 1380
CATGCCACTG CGCTCCAGCC TGGACACTAA AGGAAGACCT CTTAAAAATA GAAAGTCAAG 1440
TTCCTTTCTT CAAGTTCCAC GGGCATACAG CGTGTCATTT TGCTTAAAGA CACAGTTTCT 1500
AAGAACATAT CAACAGTGTT AAGTGAGGAC TTACCGTACT ACTTTATCAC CAGTTGGGTT 1560
AATTGGTTAA AAGAGGAATG CAATATAATT TATTTGATGA TAAACCGCTA TGACAGATAG 1620
TGGGCAATTA TTCCTTCCTT CCTCCCCCAT GCTTCTGAAA AAAAAAAAAC TACTTCAACT 1680
GGTCACTTGC CAAAAACAAA CGAAGAGATC AAACGGTCTT TTTAAGCAAA GCCAGGTTTC 1740
CGGGCCATGA ACACGTAGCT TTGCTAAGAG AAGCATGAAA TGTGAGTAGC CACAAACCTT 1800
AACAATCACG AGAACCAACA 1820
|
